Dydrogesterone


Generic Medicine Info
Administration
May be taken with or without food.
Contraindications
Known or suspected progestogen dependent neoplasms (e.g. meningioma), undiagnosed vaginal bleeding. Presence or history of serious liver disorders. Coadministration with oestrogen when oestrogen is used for prevention of endometrial hyperplasia.
Special Precautions
Patients with porphyria, herpes gestationis, otosclerosis, severe pruritus. history of depression. Hepatic impairment. Pregnancy and lactation. Patient Counselling This drug may cause mild somnolence or dizziness, if affected, do not drive or operate machinery. Monitoring Parameters Monitor liver function values. Perform breast examination.
Adverse Reactions
Significant: Bleeding and spotting, venous thromboembolism, menstrual disorders (e.g. metrorrhagia, menorrhagia, amenorrhoea, oligomenorrhoea, dysmenorrhoea and irregular menstruation), breast tenderness or pain, abnormal LFT. Gastrointestinal disorders: Nausea, vomiting. Investigations: Weight increased. Nervous system disorders: Migraine, headache, dizziness. Psychiatric disorders: Depressed mood. Skin and subcutaneous tissue disorders: Rash, pruritus, urticaria.
Potentially Fatal: Increased risk of breast cancer or rarely, ovarian cancer (when combined with oestrogen).
Drug Interactions
Increased metabolism with concomitant use of CYP3A4 inducers (e.g. carbamazepine, phenobarbital, rifampicin, efavirenz).
ATC Classification
G03DB01 - dydrogesterone ; Belongs to the class of pregnadien derivative progestogens used in progestogenic hormone preparations.
Disclaimer: This information is independently developed by CIMS based on dydrogesterone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in